-
Recent Posts
- Evaluation of marketing – grappling with the important but hard to measure outcomes
- The Friday Funny: A surrealistic mega-analysis of redisorganization theories
- Getting the facts straight on youth unemployment rates
- The Friday Funny: Negotiating the budget
- The Friday Funny: Evaluation and content expertise
Recent Comments
- Michael Scriven on Evaluation of marketing – grappling with the important but hard to measure outcomes
- Kathleen Lynch on The Friday Funny: Negotiating the budget
- Heather Nunns on Friday Funny – 10 ways of knowing you’ve been an evaluator too long
- Tarina MacDonald on 9 golden rules for commissioning a waste-of-money evaluation
- Tarina MacDonald on Valuing cultural expertise – in $$ terms
Archives
Category Archives: Strategic policy evaluation
The Friday Funny: Focusing on the important things in planning major initiatives
Evaluation is not just something we do at the end of a program, nor only impact evaluation. Some forms of evaluation are needed at the beginning of new interventions to inform the planning – evaluations in the form of needs … Continue reading
Free webinar on Evaluation and Policies
Is policy evaluation fundamentally different to program evaluation? How can lessons learned from program evaluation (such as the value of stakeholder involvement) be applied to the evaluation of policies? The next webinar in the series of monthly live webinars on … Continue reading
Posted in Development, Professional development, Strategic policy evaluation
Tagged policy, webinar
3 Comments
What constitutes “evidence”? Implications for cutting-edge, tailored treatments, and small sub-populations
In the medical profession in particular, there are some very rigid beliefs about what constitutes good enough “evidence of effectiveness” to justify offering, recommending, allowing patients to try, or even just not vehemently opposing a particular type of treatment for a patient.
There are some glimmers of hope in other sectors (e.g. in the Best Evidence Synthesis work here in New Zealand). But there are still three areas where there are very serious challenges in building a credible evidence base given the kinds of constraints and realities surrounding them. They are: (1) cutting-edge treatments; (2) treatments that are by their very nature tailored/individualized rather than standardized across patients or populations; and (3) learning what works for small sub-populations Continue reading
Jane at Real Evaluation
Patricia at CIRCLE (RMIT)